{"id":"https://openalex.org/W2005272995","doi":"https://doi.org/10.1167/iovs.15-16526","title":"A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics","display_name":"A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics","publication_year":2015,"publication_date":"2015-04-01","ids":{"openalex":"https://openalex.org/W2005272995","doi":"https://doi.org/10.1167/iovs.15-16526","mag":"2005272995","pmid":"https://pubmed.ncbi.nlm.nih.gov/25829415","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4416660"},"language":"en","primary_location":{"id":"doi:10.1167/iovs.15-16526","doi":"https://doi.org/10.1167/iovs.15-16526","is_oa":true,"landing_page_url":"https://doi.org/10.1167/iovs.15-16526","pdf_url":"https://iovs.arvojournals.org/arvo/content_public/journal/iovs/933739/i1552-5783-56-4-2755.pdf","source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative Opthalmology &amp; Visual Science","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://iovs.arvojournals.org/arvo/content_public/journal/iovs/933739/i1552-5783-56-4-2755.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054251154","display_name":"Huiyuan Hou","orcid":"https://orcid.org/0000-0003-0082-8353","observed_orcids":["https://orcid.org/0000-0003-0082-8353"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huiyuan Hou","raw_affiliation_strings":["Department of Ophthalmology Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, United States","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028791204","display_name":"Kristyn Huffman","orcid":"https://orcid.org/0000-0002-3271-2518","observed_orcids":["https://orcid.org/0000-0002-3271-2518"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristyn Huffman","raw_affiliation_strings":["Department of Ophthalmology Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, United States","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071178409","display_name":"Sandy Rios","orcid":"https://orcid.org/0000-0002-7793-8051","observed_orcids":["https://orcid.org/0000-0002-7793-8051"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandy Rios","raw_affiliation_strings":["Department of Ophthalmology Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, United States","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101974691","display_name":"William R. Freeman","orcid":"https://orcid.org/0000-0001-9979-2500","observed_orcids":["https://orcid.org/0000-0001-9979-2500"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William R. Freeman","raw_affiliation_strings":["Department of Ophthalmology Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, United States","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059375688","display_name":"Michael J. Sailor","orcid":"https://orcid.org/0000-0002-4809-9826","observed_orcids":["https://orcid.org/0000-0002-4809-9826"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Sailor","raw_affiliation_strings":["Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California, United States","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039407742","display_name":"Lingyun Cheng","orcid":"https://orcid.org/0000-0002-0748-5173","observed_orcids":["https://orcid.org/0000-0002-0748-5173"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lingyun Cheng","raw_affiliation_strings":["Department of Ophthalmology Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, California, United States","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5039407742"],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":{"value":1850,"currency":"USD","value_usd":1850},"apc_paid":null,"fwci":3.5065,"has_fulltext":true,"cited_by_count":27,"citation_normalized_percentile":{"value":0.91718497,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"56","issue":"4","first_page":"2755","last_page":"2755"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.8734999895095825,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.8734999895095825,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0674000009894371,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12484","display_name":"Retinopathy of Prematurity Studies","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/proliferative-vitreoretinopathy","display_name":"proliferative vitreoretinopathy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/controlled-drug-delivery","display_name":"controlled drug delivery","score":0.8109999895095825},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.9649999737739563},{"id":"https://openalex.org/keywords/retinal-detachment","display_name":"retinal detachment","score":0.6779999732971191},{"id":"https://openalex.org/keywords/rabbit-model","display_name":"rabbit model","score":0.4909999966621399},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5149999856948853},{"id":"https://openalex.org/keywords/antiproliferative-therapy","display_name":"antiproliferative therapy","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.9180054664611816},{"id":"https://openalex.org/C2779059073","wikidata":"https://www.wikidata.org/wiki/Q7249608","display_name":"Proliferative vitreoretinopathy","level":4,"score":0.8699307441711426},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6557972431182861},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6423575282096863},{"id":"https://openalex.org/C2780428090","wikidata":"https://www.wikidata.org/wiki/Q625164","display_name":"Retinal detachment","level":3,"score":0.6072458624839783},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6024775505065918},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.517422080039978},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4862917363643646},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41146302223205566},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.3894166052341461},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2874913215637207},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.20501455664634705}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003630","descriptor_name":"Daunorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003630","descriptor_name":"Daunorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012825","descriptor_name":"Silicon","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014822","descriptor_name":"Vitreous Body","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016062","descriptor_name":"Porosity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018630","descriptor_name":"Vitreoretinopathy, Proliferative","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018630","descriptor_name":"Vitreoretinopathy, Proliferative","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1167/iovs.15-16526","doi":"https://doi.org/10.1167/iovs.15-16526","is_oa":true,"landing_page_url":"https://doi.org/10.1167/iovs.15-16526","pdf_url":"https://iovs.arvojournals.org/arvo/content_public/journal/iovs/933739/i1552-5783-56-4-2755.pdf","source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative Opthalmology &amp; Visual Science","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4416660","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4416660","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Invest Ophthalmol Vis Sci","raw_type":"Text"},{"id":"pmid:25829415","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25829415","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative ophthalmology & visual science","raw_type":"Journal Article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt3gg557gb","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/3gg557gb","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science, vol 56, iss 4","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1167/iovs.15-16526","doi":"https://doi.org/10.1167/iovs.15-16526","is_oa":true,"landing_page_url":"https://doi.org/10.1167/iovs.15-16526","pdf_url":"https://iovs.arvojournals.org/arvo/content_public/journal/iovs/933739/i1552-5783-56-4-2755.pdf","source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative Opthalmology &amp; Visual Science","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2179675123","display_name":null,"funder_award_id":"P30EY022589","funder_id":"https://openalex.org/F4320306811","funder_display_name":"Research to Prevent Blindness"},{"id":"https://openalex.org/G4217451883","display_name":null,"funder_award_id":"EY 020617","funder_id":"https://openalex.org/F4320337350","funder_display_name":"National Eye Institute"},{"id":"https://openalex.org/G631213127","display_name":null,"funder_award_id":"P30EY022589","funder_id":"https://openalex.org/F4320332603","funder_display_name":"University of California, San Diego"},{"id":"https://openalex.org/G692105573","display_name":"Porous Silicon Particles for Sustained Intravitreal Drug Delivery","funder_award_id":"R01EY020617","funder_id":"https://openalex.org/F4320337350","funder_display_name":"National Eye Institute"},{"id":"https://openalex.org/G9000910452","display_name":"NEI Center Core Grant for Vision Research","funder_award_id":"P30EY022589","funder_id":"https://openalex.org/F4320337350","funder_display_name":"National Eye Institute"}],"funders":[{"id":"https://openalex.org/F4320306811","display_name":"Research to Prevent Blindness","ror":"https://ror.org/04drjs621"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332603","display_name":"University of California, San Diego","ror":"https://ror.org/0168r3w48"},{"id":"https://openalex.org/F4320337350","display_name":"National Eye Institute","ror":"https://ror.org/03wkg3b53"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005272995.pdf","grobid_xml":"https://content.openalex.org/works/W2005272995.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W32866635","https://openalex.org/W95937414","https://openalex.org/W117619303","https://openalex.org/W170946976","https://openalex.org/W297012981","https://openalex.org/W818694610","https://openalex.org/W1497840515","https://openalex.org/W1543243672","https://openalex.org/W1578071857","https://openalex.org/W1837222401","https://openalex.org/W1971841919","https://openalex.org/W1973571228","https://openalex.org/W1975606985","https://openalex.org/W1978005285","https://openalex.org/W1978694636","https://openalex.org/W1996001880","https://openalex.org/W2011630968","https://openalex.org/W2020492718","https://openalex.org/W2024770523","https://openalex.org/W2026524260","https://openalex.org/W2028925055","https://openalex.org/W2057722826","https://openalex.org/W2062053565","https://openalex.org/W2065580534","https://openalex.org/W2065790323","https://openalex.org/W2084382082","https://openalex.org/W2085814899","https://openalex.org/W2097213635","https://openalex.org/W2103657369","https://openalex.org/W2105769934","https://openalex.org/W2141843479","https://openalex.org/W2144362409","https://openalex.org/W2150133429","https://openalex.org/W2158269015","https://openalex.org/W2810212157","https://openalex.org/W4235183969"],"related_works":["https://openalex.org/W3094620047","https://openalex.org/W2394900600","https://openalex.org/W1605950388","https://openalex.org/W2222795559","https://openalex.org/W2024770523","https://openalex.org/W1979314201","https://openalex.org/W2074845742","https://openalex.org/W2016392800","https://openalex.org/W2473106229","https://openalex.org/W2869759688"],"abstract_inverted_index":{"PURPOSE:":[0],"Proliferative":[1,180],"vitreoretinopathy":[2,181],"(PVR)":[3],"is":[4],"the":[5,26,189,194,199,205,228,239,252],"most":[6],"common":[7],"cause":[8],"of":[9,45,56,104,117,131,139,146,242,247,259],"poor":[10],"visual":[11],"outcomes":[12],"in":[13,29,32,92,188,193,198,204,227],"association":[14],"with":[15,134,182],"retinal":[16,184],"detachment":[17,185],"surgeries":[18],"and":[19,49,66,89,142,166,202,249],"ocular":[20],"trauma.":[21],"Daunorubicin":[22],"(DNR)":[23],"has":[24],"shown":[25,38],"strongest":[27],"efficacy":[28,90],"proliferation":[30],"inhibition":[31],"vitro.":[33],"However,":[34],"clinical":[35],"studies":[36],"have":[37],"only":[39],"mild":[40],"effect":[41],"owing":[42],"to":[43,72,160],"limitations":[44],"narrow":[46],"therapeutic":[47,240],"window":[48,241],"short":[50],"vitreous":[51,67,129,229],"half-life.":[52],"METHODS:":[53],"Three":[54],"milligrams":[55],"DNR-loaded":[57],"particles":[58,156,223],"were":[59,69,79,157],"intravitreally":[60],"injected":[61],"into":[62],"18":[63],"pigmented":[64],"rabbits,":[65],"samples":[68],"collected":[70],"up":[71],"84":[73],"days":[74,116,133],"for":[75,81,230],"analysis.":[76],"Thirty-seven":[77],"rabbits":[78],"used":[80],"a":[82,93,98,128,135,143,245,257],"dose-escalation":[83],"(1,":[84],"3,":[85],"6":[86],"mg)":[87],"safety":[88],"study":[91],"rabbit":[94],"PVR":[95,164,167],"model":[96],"using":[97],"pretreatment":[99],"design.":[100],"RESULTS:":[101],"Loading":[102],"efficiency":[103],"DNR":[105,137,243],"was":[106,170,186],"108.55":[107],"\u00b1":[108],"12":[109],"\u03bcg":[110],"per":[111],"1":[112],"mg":[113],"particles.":[114],"Eighty-four":[115],"follow-up":[118],"did":[119],"not":[120],"reveal":[121],"any":[122],"adverse":[123],"reaction.":[124],"Pharmacokinetic":[125],"analysis":[126],"demonstrated":[127],"half-life":[130],"29":[132,147],"maximum":[136],"concentration":[138,145,255],"178":[140],"ng/mL":[141,148],"minimum":[144,253],"at":[149,231],"day":[150],"84.":[151],"Daunorubicin-loaded":[152,221],"porous":[153],"silicon":[154],"(pSi)":[155],"dosed":[158],"8":[159],"9":[161],"weeks":[162],"before":[163],"induction,":[165],"severity":[168],"score":[169],"dose":[171],"dependent":[172],"(Spearman":[173],"\u03c1":[174,214],"=":[175,178,212,215],"-0.25,":[176],"P":[177,217],"0.0005).":[179],"tractional":[183],"88%":[187],"control":[190],"group,":[191,196,201],"63%":[192],"low-dose":[195],"14%":[197],"medium-dose":[200],"0%":[203],"high-dose":[206],"group":[207],"(Cochran-Armitage":[208],"Trend":[209],"Test,":[210],"Z":[211],"8.99,":[213],"-0.67,":[216],"<":[218],"0.0001).":[219],"CONCLUSIONS:":[220],"pSi":[222],"can":[224],"safely":[225],"reside":[226],"least":[232],"3":[233],"months.":[234],"The":[235],"pSi-based":[236],"delivery":[237],"expanded":[238],"by":[244,256],"factor":[246,258],"862":[248],"drove":[250],"down":[251],"effective":[254],"175.":[260]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}